// App-Quantinova.ai

3098.0 : First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO.

Researchers

Presenter

  • Daniel Vilarim Araujo

Principal Investigators

  • Tira Jing Ying Tan

  • Alya Abbas Heirali

  • Pierre H.H. Schneeberger

  • Thiago Pimentel Muniz

  • Bo Chen

  • Lee-Anne Stayner

  • Kathy Xia

  • Aaron Richard Hansen

  • Ben X Wang

  • David Hogg

  • Kyla Cochrane

  • Shawn Langer

  • Nissim Mashiach

  • Wei Xu

  • Lillian L. Siu

  • Bryan Coburn

  • Anna Spreafico

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • National Cancer Centre Singapore, Singapore, Singapore

  • University Health Network, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Princess Margaret - University Health Network, Toronto, ON, CA

  • NuBiyota LLC, Guelph, ON, Canada

  • NuBiyota LLC, Guelph, ON, Canada

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Cohort

Phase

  • NA

Study Id's

  • NCT03686202

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved